Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer.
about
Historical review of the causes of cancerMate-Pair Sequencing as a Powerful Clinical Tool for the Characterization of Cancers with a DNA Viral EtiologyMatrix and backstage: cellular substrates for viral vaccinesPerspectives for therapeutic HPV vaccine developmentMultiple-integrations of HPV16 genome and altered transcription of viral oncogenes and cellular genes are associated with the development of cervical cancerCritical evaluation of HPV16 gene copy number quantification by SYBR green PCR.Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses.Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia.Genotype-specific methylation of HPV in cervical intraepithelial neoplasia.Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage.Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women.Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study.Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer.Sequence variation in the E2-binding domain of HPV16 and biological function evaluation in Tunisian cervical cancers.Differential methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation.Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues.Diagnosis of 25 genotypes of human papillomaviruses for their physical statuses in cervical precancerous/cancerous lesions: a comparison of E2/E6E7 ratio-based vs. multiple E1-L1/E6E7 ratio-based detection techniquesHPV genotyping and site of viral integration in cervical cancers in Indian women.Human papillomavirus-16 presence and physical status in lung carcinomas from AsiaSome novel insights on HPV16 related cervical cancer pathogenesis based on analyses of LCR methylation, viral load, E7 and E2/E4 expressionsViral load, integration and methylation of E2BS3 and 4 in human papilloma virus (HPV) 16-positive vaginal and vulvar carcinomas.HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.Genetic variation of human papillomavirus type 16 in individual clinical specimens revealed by deep sequencing.Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression.Human papillomavirus and Epstein-Barr virus infections in breast cancer from chile.Human papillomavirus in upper digestive tract tumors from three countries.Genomic instability of the host cell induced by the human papillomavirus replication machineryEffects of Methylation Status of CpG Sites within the HPV16 Long Control Region on HPV16-Positive Head and Neck Cancer CellsPhysical state and viral load as predictive biomarkersfor persistence and progression of HPV16-positive cervical lesions: results from a population based long-term prospective cohort studyElucidating the spatially varying relation between cervical cancer and socio-economic conditions in England.Human papillomavirus infection and immunohistochemical expression of cell cycle proteins pRb, p53, and p16(INK4a) in sinonasal diseases.High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasiaKnock down of p53 or its ubiquitin ligase E6AP does not affect the sensitivity of human papillomavirus-positive cervical cancer cells to cisplatin.Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.Study of association and molecular analysis of human papillomavirus in breast cancer of Indian patients: Clinical and prognostic implication.Laboratory and clinical aspects of human papillomavirus testingComparative study of HPV16 integration in cervical lesions between ethnicities with high and low rates of infection with high-risk HPV and the correlation between integration rate and cervical neoplasia.Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low-grade cervical lesion to invasive cancer.Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile.Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China
P2860
Q26767036-074D9004-0272-4A21-889D-B1A24CEA7DFAQ26799320-5A95544A-BC09-47E1-B159-4E99CD9889DBQ27025941-60CD9E51-2FD2-4CC2-B4C5-B22D092EE868Q28069272-96816C26-3AEF-4416-BD05-D5FFBE1AC581Q31172479-F77C1202-D69F-4073-AF01-0DA550D2D4A6Q33354767-5FB9250F-02F9-468C-A2BE-96CEB19A7315Q33434433-9F2FF901-861E-4009-986A-40D821D9F1CDQ33733302-0E53E569-94DA-4E6B-B98C-CAF82777B8D5Q33735179-A7A1BDF6-A170-43FD-B575-67BACB507D02Q33740118-80AC68E7-4D65-4F63-A04A-FEDCDE7655A9Q33744518-E21F8C88-D937-463D-9417-2CC08E21DDD7Q33756179-5FE6534E-8945-4166-90E7-A061CA645728Q33833645-A9F9DED2-647E-4A84-8557-E9503A367D85Q33852197-05C305EC-8632-4DE0-B925-86AF180EA0E8Q34019049-12EADBF2-819A-4ACB-9DB9-1959FA340C6AQ34217919-4417FAE3-2634-42E1-AE62-0CDA267B75C0Q34317107-FE2C6D7D-6400-416F-A56D-4832DCA271A0Q34345540-B0BF8DB8-CE49-4075-8D73-BA8567A25E5CQ34366447-1B70CED0-9207-41A0-AC01-A39DCA21A35BQ34412697-9259094C-FB4D-4138-9414-C9EEBD1C2437Q34506898-228613E6-87AC-4D8F-835F-0950B00526E8Q34566683-A7261C14-4345-473B-8382-573F7FFBD365Q35043973-845370D8-156F-493F-8171-FB4134EB327FQ35106230-0AE4C82C-ABBD-41E2-8A64-0ED6C719324FQ35121773-2A9ED2A5-0AC5-4483-B46F-76E7DCF865BCQ35638798-CFB59300-757F-438E-9894-B8A39FB1EDD2Q35752761-D55C9B41-4842-4CAE-8DC3-0B705B48B062Q35824357-8BB9F087-4A51-4F02-950F-59A7F210AE97Q35832915-922BDE79-9B20-47EE-8D4B-F4ACBF2B090AQ35834920-3097C7C8-28E4-476C-A859-18BC777592F7Q35914911-7D91B016-6BAD-400F-845B-FBE57B283125Q35989077-93C540E1-D87C-4876-8C53-283DA1869678Q36003210-E8F024C1-3F6B-48C6-99D3-03B65EC1000AQ36012702-B5A5D158-CEB4-49A3-8DAD-E258BA7FB9CCQ36292980-6063A128-946E-428B-A9B7-0A0B0BE70345Q36311573-3D8999EB-0E82-44F5-B789-A633C2D22EB3Q36334581-32945AD5-176A-4A13-BA3E-13321DC5DE39Q36539864-E8D57348-7F11-4049-85B6-6E89D97FB9E2Q36608615-5AB89771-DDFA-4806-8B70-389677D67429Q36609586-3F6CE013-958C-4B32-B224-02187E900CAF
P2860
Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Human papillomavirus type 16 i ...... d in invasive cervical cancer.
@ast
Human papillomavirus type 16 i ...... d in invasive cervical cancer.
@en
Human papillomavirus type 16 i ...... d in invasive cervical cancer.
@nl
type
label
Human papillomavirus type 16 i ...... d in invasive cervical cancer.
@ast
Human papillomavirus type 16 i ...... d in invasive cervical cancer.
@en
Human papillomavirus type 16 i ...... d in invasive cervical cancer.
@nl
prefLabel
Human papillomavirus type 16 i ...... d in invasive cervical cancer.
@ast
Human papillomavirus type 16 i ...... d in invasive cervical cancer.
@en
Human papillomavirus type 16 i ...... d in invasive cervical cancer.
@nl
P2093
P2860
P1476
Human papillomavirus type 16 i ...... nd in invasive cervical cancer
@en
P2093
Cheri L Peyton
Hernan Vargas
Nancy E Joste
P2860
P304
P356
10.1128/JCM.44.5.1755-1762.2006
P407
P577
2006-05-01T00:00:00Z